Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03015025
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2017-01-02
Brief Title:
Pharmacogenetic Dosage Algorithm for Acenocoumarol
Sponsor:
Organization:
Instituto de Investigación Hospital Universitario La Paz
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Patients consent was requested for the preservation of their DNA sample in case of new genes related to the pharmacokinetics or pharmacodynamics of acenocoumarol are discovered in the future
Enrollment Count:
340
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 38953 |
Who Masked List: